R B Credo
Overview
Explore the profile of R B Credo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
211
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Szczepankiewicz B, Liu G, Jae H, Tasker A, Gunawardana I, von Geldern T, et al.
J Med Chem
. 2001 Dec;
44(25):4416-30.
PMID: 11728187
During a screen for compounds that could inhibit cell proliferation, a series of new tubulin-binding compounds was identified with the discovery of oxadiazoline 1 (A-105972). This compound showed good cytotoxic...
2.
Gwaltney 2nd S, Imade H, Li Q, Gehrke L, Credo R, Warner R, et al.
Bioorg Med Chem Lett
. 2001 Jun;
11(13):1671-3.
PMID: 11425534
The synthesis and biological evaluation of novel sulfonate analogues of E-7010 are reported. Several of the compounds are potent inhibitors of cell proliferation and tubulin polymerization. Importantly, these compounds are...
3.
Gwaltney 2nd S, Imade H, Barr K, Li Q, Gehrke L, Credo R, et al.
Bioorg Med Chem Lett
. 2001 Apr;
11(7):871-4.
PMID: 11294380
Sulfonate analogues of combretastatin A-4 have been prepared. These compounds compete with colchicine and combretastatin A-4 for the colchicine binding site on tubulin and are potent inhibitors of tubulin polymerization...
4.
Han E, Gehrke L, Tahir S, Credo R, Cherian S, Sham H, et al.
Eur J Cancer
. 2000 Aug;
36(12):1565-71.
PMID: 10930805
Beta(beta)-tubulin isotype variation has recently been implicated in the modulation of resistance to paclitaxel in human lung cancer cells and in primary human ovarian tumour samples. Whether alpha-tubulin is involved...
5.
Credo R, Burke S
J Vasc Interv Radiol
. 1995 Nov;
6(6 Pt 2 Suppl):8S-18S.
PMID: 8770836
The purpose of this review is to provide a biochemical characterization of recombinant prourokinase (r-ProUK [ABT-187]), including a description of its clot-specific fibrinolytic mechanism. In addition, the preclinical data will...
6.
Curtis C, Janus T, Credo R, Lorand L
Ann N Y Acad Sci
. 1983 Jun;
408:567-76.
PMID: 6135381
No abstract available.
7.
Credo R, Curtis C, Lorand L
Biochemistry
. 1981 Jun;
20(13):3770-8.
PMID: 6115670
Fibrinogen (approximately 10(-5) M) labilizes heterologous interactions within the thrombin-modified factor XIII zymogen (i.e., XIII' = a2'b2) so that, in the time frame (ca. 10 min) of normal clotting in...
8.
Lorand L, Credo R, Janus T
Methods Enzymol
. 1981 Jan;
80 Pt C:333-41.
PMID: 7341914
No abstract available.
9.
Gudewicz P, Molnar J, Lai M, Beezhold D, Siefring Jr G, Credo R, et al.
J Cell Biol
. 1980 Nov;
87(2 Pt 1):427-33.
PMID: 7430249
The present study demonstrates the ability of plasma fibronectin or cold-insoluble globulin (Clg) to promote the uptake of 125I-labeled, gelatin-coated latex beads (g-Ltx*) by monolayers of peritoneal macrophages (PM). The...
10.
Molnar J, Gelder F, Lai M, Siefring Jr G, Credo R, Lorand L
Biochemistry
. 1979 Sep;
18(18):3909-16.
PMID: 114206
No abstract available.